Treatment of behavioral and mood disturbances in Dementia

Generations

Volumn 23, Issue 3, 1999, Pages 50-56

  Teri, Linda ^a   Logsdon, Rebecca G ^a   Schindler, Rachel J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002462855     PISSN: 07387806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bodick, N. C., et al. 1997. "Effects of Xanomeline, a Selective Muscarinic Receptor Agonist on Cognitive Function and Behavioral Symptoms in Alzheimer's Disease." Archives of Neurology 54:465-73.
2. Burns, A., Jacoby, R., and Levy, R. 1990. "Behavioral Abnormalities and Psychiatric Symptoms in Alzheimer's Disease: Preliminary Findings." International Psychogeriatrics 2:25-36.
3. Carlson, D. L., et al. 1995. "Management of Dementia-Related Behavioral Disturbances: A Nonpharmacological Approach." Mayo Clinic Proceedings 70:1108-115.
4. Coccaro, E. F., et al. 1990. "Pharmacologic Treatment of Noncognitive Behavioral Disturbances in Elderly Demented Patients." American Journal of Psychiatry 147:1640-645.
5. Collaborative Working Group on Clinical Trial Evaluations. 1998. "Treatment of Special Populations with the Atypical Antipsychotics." Journal of Clinical Psychiatry 59(Suppl. 12):46-52.
6. Cummings, J. L., and Kaufer, D. 1996. "Neuropsychiatric Aspects of Alzheimer's Disease: The Cholinergic Hypothesis Revisited." Neurology 47:876-83.
7. Devanand, D. P., et al. 1998. "A Randomized, Placebo-Controlled Trial of Haloperidol Treatment for Psychosis and Disruptive Behaviors in Alzheimer's Disease." American Journal of Psychiatry 155(11):1512-520.
8. Devanand, D. P., et al. 1989. "A Pilot Study of Haloperidol Treatment of Psychosis and Behavioral Disturbance in Alzheimer's Disease." Archives of Neurology 46:854-57.
9. Ferris, S. H., and Mittelman, M. S. 1996. "Behavioral Treatment for Alzheimer's Disease." International Psychogeriatrics 8:87-90.
10. Gallagher, D. E., and Thompson, L. W. 1983. "Effectiveness of Psychotherapy for Both Endogenous and Nonendogenous Depression in Older Adult Outpatients." Journal of Gerontology 38:707-12.
11. Gleason, R. P., and Schneider, L. S. 1990. "Carbamazepine Treatment of Agitation in Alzheimer's Outpatients Refractory to Neuroleptics." Journal of Clinical Psychiatry 51:115-18.
12. Haley, W. E., Brown, S. L., and Levine, E. G. 1987. "Experimental Evaluation of the Effectiveness of Group Intervention for Dementia Caregivers." Gerontologist 27:376-82.
13. Katzman, R. 1985. "Clinical Presentation of the Course of Alzheimer's Disease: The Atypical Patient." In C. F. Rose, ed., Modern Approaches to the Dementias: Part II. Switzerland: Basel.
14. Kaufer, D. L., Cummings, J. L., and Christine, D. 1996. "Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study." Journal of Geriatric Psychiatry and Neurology 9:1-6.
15. Lazarus, L. W., et al. 1987. "Frequency and Presentation of Depressive Symptoms in Patients with Primary Degenerative Dementia." American Journal of Psychiatry 144:41-5.
16. Lebert, F., Pasquier, F., and Petit, H. 1994. "Behavioral Effects of Trazodone in Alzheimer's Disease." Journal of Clinical Psychiatry 55:536-38.
17. Leibovici, A., and Tariot, P. N. 1988. "Agitation Associated with Dementia: A Systematic Approach to Treatment." Pharmacology Bulletin 24(1):49-53.
18. Logsdon, R., et al. 1997. "Family and Caregiver Issues in the Treatment of Patients with Alzheimer's Disease." Seminars in Clinical Neuropsychiatry 2(2):138-51.
19. Logsdon, R.G., and Teri, L. 1997. "The Pleasant Events Schedule-AD: Psychometric Properties and Relationship to Depression and Cognition in Alzheimer's Disease Patients." Gerontologist 37(1):40-5.
20. Lott, A. D., McElyoy, S. L., and Keys, M. A. 1995. "Valproate in the Treatment of Behavioral Agitation in Elderly Patients with Dementia." Journal of Neuropsychiatry and Clinical Neurosciences 7(3):314-19.
21. Maas, M. 1988. "Management of Patients with Alzheimer's Disease in Long-Term Care Facilities." Nursing Clinics of North America 23(1):57-68.
22. Mellow, A. M., Solano-Lopez, C., and Davis, S. 1993. "Sodium Valproate in the Treatment of Behavioral Disturbance in Dementia." Journal of Geriatric Psychiatry and Neurology 6:205-9.
23. Mittelman, M. S., et al. 1995. "A Comprehensive Support Program: Effect on Depression in Spouse-Caregivers of AD Patients." Gerontologist 35(6):792-802.
24. Mittelman, M. S., et al. 1996. "A Family Intervention to Delay Nursing Home Placement of Patients with Alzheimer's Disease: A Randomized Controlled Trial." Journal of the American Medical Association 276:1725-31.
25. Morris, J. C., et al. 1998. "Metrifonate Benefits Cognitive, Behavioral, and Global Function in Patients with Alzheimer's Disease." Neurology 50:1222-30.
26. Nyth, A. L., and Gottfries, C. G. 1990. "The Clinical Efficacy of Citalopram in the Treatment of Emotional Disturbances in Dementia Disorders: A Nordic Multicentre Study." British Journal of Psychiatry 157:894-901.
27. Olafsson, K., et al. 1992. "Fluvoxamine in the Treatment of Demented Elderly Patients: A Double-Blind, Placebo-Controlled Study." Acta Psychiatrica Scandinavica 84:453-56.
28. Pickar, D. 1995. "Prospects for Pharmacotherapy of Schizophrenia." Lancet 345:557-62.
29. Rabins, P. V. 1994. "Non-Cognitive Symptoms in Alzheimer's Disease." In R. D. Terry, R. Katzman, and K. L. Bick, eds., Alzheimer's Disease. New York: Raven Press.
30. Ragneskog, H., et al. 1996. "Long-Term Treatment of Elderly Individuals with Emotional Disturbances: An Open Study with Citalopram." International Psychogeriatrics 8(4):659-68.
31. Raskind, M. A. 1989. "Organic Mental Disorders." In E. Busse and D. Blazer, eds., Geriatric Psychiatry. Washington, D.C.: American Psychiatric Press.
32. Reifler, B. V., et al. 1989. "Double-Blind Trial of Imipramine in Alzheimer's Disease Patients with and without Depression." American Journal of Psychiatry 146:45-9.
33. Reisberg, B., et al. 1987. "Behavioral Symptoms in Alzheimer's Disease: Phenomenology and Treatment." Journal of Clinical Psychiatry 48(Suppl. 5):9-15.
34. Reynolds, C. F., et al. 1987. "Open-Trial Response to Antidepressant Treatment in Elderly Patients with Mixed Depression and Cognitive Impairment." Psychiatry Research 21(2):111-22.
35. Salzman, C. 1988. "Treatment of Agitation, Anxiety and Depression in Dementia." Psychopharmacology Bulletin 24(1):39-42.
36. Schneider, L. S., Pollack, V. E., and Lyness, S. A. 1990. "A Meta-Analysis of Controlled Trials of Neuroleptic Treatment in Dementia." Journal of the American Geriatrics Society 38:553-63.
37. Sky, A. J., and Grossberg, G. T. 1994. "The Use of Psychotropic Medication in the Management of Problem Behaviors in the Patient with Alzheimer's Disease." Medical Clinics of North America 78(4):811-22.
38. Smith, D. A., and Perry, P. J. 1992. "Nonneuroleptic Treatment of Disruptive Behavior in Organic Mental Syndromes." The Annals of Pharmacotherapy 26(11):1400-408.
39. Steele, C., et al. 1990. "Psychiatric Symptoms and Nursing Home Placement of Patients with Alzheimer's Disease." American Journal of Psychiatry 147(8):1049-51.
40. Swearer, J. M., et al. 1988. "Troublesome and Disruptive Behaviors in Dementia: Relationships to Diagnosis and Disease Severity." Journal of the American Geriatrics Society 36:784-90.
41. Teri, L. 1990. Managing and Understanding Behavior Problems in Alzheimer's Disease and Related Disorders. Videotape training program. Seattle: University of Washington.
42. Teri, L., et al. 1989. "Behavioral Disturbance, Cognitive Dysfunction, and Functional Skill. Prevalence and Relationship in Alzheimer's Disease." Journal of the American Geriatrics Society 37:109-16.
43. Teri, L., and Logsdon, R. G. 1991. "Identifying Pleasant Activities for Alzheimer's Disease Patients: The Pleasant Events Schedule-AD." Gerontologist 31:124-27.
44. Teri, L., et al. Under review. "Treatment of Agitation in Alzheimer's Disease Patients: A Randomized Placebo Controlled Clinical Trial."
45. Teri, L., et al. In press. "Treatment for Agitation in Dementia Patients: A Behavior Management Approach." Psychotherapy.
46. Teri, L., et al. 1997. "Behavioral Treatment of Depression in Dementia Patients: A Controlled Clinical Trial." Journals of Gerontology B: Psychological Sciences and Social Sciences 52B(4):P159-P166.
47. Teri, L., and Reifler, B. V. 1987. "Depression and Dementia." In L. Carstensen and B. Edelstein, eds., Handbook of Clinical Gerontology. New York: Pergamon Press.
48. Teri, L., et al. 1992. "Assessment of Behavioral Problems in Dementia: The Revised Memory and Behavior Problems Checklist." Psychology and Aging, 7:622-31.
49. Toseland, R. W., Rossiter, C.M., and Labrecque, M.S. 1989. "The Effectiveness of Peer-Led and Professionally Led Groups to Support Family Caregivers." Gerontologist 29:465-71.
50. Weiler, P. G., Mungas, D., and Bernick, C. 1988. "Propranolol for the Control of Disruptive Behavior in Senile Dementia." Journal of Geriatric Psychiatry and Neurology 1:226-30.
51. Weiner, M. F., Debus, J. R., and Goodkin, K. 1991. "Pharmacological Management and Treatment of Dementia and Secondary Symptoms." In M. F. Weiner, ed. The Dementias: Diagnosis and Management. Washington D.C.: American Psychiatric Press.
52. Weiner, M. F., et al. 1996. "Pharmacologic Management and Treatment of Dementia and Secondary Symptoms." In M. F. Weiner, ed., The Dementias: Diagnosis, Management, and Research, 2nd edition. Washington, D.C.: American Psychiatric Press.
53. Whitehouse, P. J., et al. 1981. "Alzheimer's Disease: Evidence for Selective Loss of Cholinergic Neurons in the Nucleus Basalis." Annals of Neurology 10:122-26.
54. Wragg, R. E., and Jeste, D. V. 1988. "Neuroleptics and Alternative Treatments. Management of Behavioral Symptoms and Psychosis in Alzheimer's Disease and Related Conditions." Psychiatric Clinics of North America 11(1):196-213.
55. Zarit, S. H., Orr, N. K., and Zarit, J. M. 1985. The Hidden Victims of Alzheimer's Disease: Families Under Stress. New York: New York University Press.